Asxl1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-protein
| Protein Name | ASXL1 |
| Gene | ASXL1 |
| UniProt ID | Q8IZY3 |
| PDB Structure | Not available |
| Molecular Weight | ~165 kDa |
| Subcellular Localization | Nucleus (chromatin) |
| Protein Family | ASXL family |
::
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
ASXL1 is a 1635-amino acid protein containing multiple domains including an ASXH (ASXL homology) domain. It functions as a scaffold protein that recruits chromatin-modifying enzymes to specific genomic loci.
ASXL1 is a chromatin-binding protein involved in epigenetic regulation. It interacts with the Polycomb repressive complex 2 (PRC2) to regulate H3K27 methylation and with the LSD1 complex to regulate H3K4 methylation. ASXL1 plays critical roles in development, cell fate decisions, and gene expression 1.
De novo heterozygous mutations in ASXL1 cause Bohring-Opitz syndrome, a neurodevelopmental disorder characterized by microcephaly, distinctive facial features, and developmental delay. The mutations lead to loss of ASXL1 function and disrupted epigenetic regulation 2.
ASXL1 dysregulation contributes to FTD through altered epigenetic control of microglial genes, leading to neuroinflammation. Targeting epigenetic modifiers is being explored as a therapeutic approach 3.
The study of Asxl1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.